MSc
SEBIA, France
Mr. Zarouki Mouktadi is a Proteomics and Mass Spectrometry Study Engineer at Sebia, specializing in research and development, validation, and clinical diagnostic applications. With a keen focus on designing proteomics analysis methods and executing experiments, he contributes significantly to the company's innovation.
Zarouki collaborates closely with research and clinical departments in European universities and hospitals, fostering knowledge exchange and driving advancements in the field. His expertise in proteomics and mass spectrometry is grounded in a Master's degree in Structural and Functional Biochemistry from the University of Paul Sabatier Toulouse III and over five years of hands-on experience.
Previously, he highly contributed to biomarker research at DéTROI Research Group, focusing on targeted analysis methods and absolute quantification of apolipoproteins in SARS-CoV-2 patients. He honed his skills as a Hospital Mass Spectrometry and Proteomics Engineer at CHU de Poitiers, where he developed protocols for diagnosing monoclonal immunoglobulin Free Light chain deposits.
Zarouki's strong scientific and technical foundation, coupled with his curiosity and collaborative spirit, make him a valuable asset to the team. He is committed to expanding his knowledge of disease and mass spectrometry technologies to drive innovative diagnostic solutions.
Skills: Proteomics, Mass Spectrometry, LC-MS, Data Analysis, Bioinformatics, Biochemistry, Cell Biology, Sample Preparation, Microdissection Laser, De Novo Sequencing, Organization, Problem-solving, Teamwork, Adaptability.
Education:
Master's Degree in Structural and Functional Biochemistry, University of Paul Sabatier Toulouse III (2016-2018)
Bachelor's Degree in Biochemistry, University of La Réunion (2013-2016)
Experience:
Proteomics and Mass Spectrometry Study Engineer, Sebia (Present)
Hospital Mass Spectrometry Engineer, CHU de Poitiers (2021-2022)
Mass Spectrometry Study Engineer, DéTROI (2019-2021)